Partager cet article

Una DAO para enfermedades: cómo Vibe Bio planea reestructurar la financiación de la biotecnología

El fundador de Vibe Bio no estaba entusiasmado con la creación de una DAO, pero descentralizar la investigación de medicamentos podría solucionar un problema espinoso y trágico.

Large pharmaceutical companies focus on fighting the most common (and therefore profitable) disorders. A new DAO wants to restructure incentives and boost research into rarer diseases. (Morsa/Getty Images)
Large pharmaceutical companies focus on fighting the most common (and therefore profitable) disorders. A new DAO wants to restructure incentives and boost research into rarer diseases. (Morsa/Getty Images)